Cargando…

miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer

BACKGROUND: Different breast cancer subtypes show distinct tropisms for sites of metastasis. Notably, the lung is the most common site for the first distant recurrence in triple-negative breast cancer (TNBC). The identification of novel biomarkers for lung metastasis is of great importance to improv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jin, Song, Cailu, Tang, Hailin, Zhang, Chao, Tang, Jun, Li, Xing, Chen, Bo, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477310/ https://www.ncbi.nlm.nih.gov/pubmed/28629464 http://dx.doi.org/10.1186/s13058-017-0865-y

Ejemplares similares

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
por: Liu, Peng, et al.
Publicado: (2016)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
por: Liu, Peng, et al.
Publicado: (2018)

CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1
por: Xiao, Weikai, et al.
Publicado: (2019)

MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
por: Yan, Haijiao, et al.
Publicado: (2017)

miR-629 targets FOXO3 to promote cell apoptosis in gastric cancer
por: Li, Ming, et al.
Publicado: (2020)

miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
por: Tang, Hailin, et al.
Publicado: (2019)

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer
por: Zhao, Zitong, et al.
Publicado: (2019)

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: Huang, Xiaojia, et al.
Publicado: (2017)

MiR‐629 regulates hypoxic pulmonary vascular remodelling by targeting FOXO3 and PERP
por: Zhao, Mei, et al.
Publicado: (2019)

miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
por: Wu, Ying, et al.
Publicado: (2016)

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
por: Zhao, Zitong, et al.
Publicado: (2023)

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
por: Liu, Xiaoping, et al.
Publicado: (2015)

miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015)

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
por: Xiao, Xiangsheng, et al.
Publicado: (2016)

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: He, Rongfang, et al.
Publicado: (2017)

circSMAD2 inhibits the epithelial–mesenchymal transition by targeting miR-629 in hepatocellular carcinoma
por: Zhang, Xianwei, et al.
Publicado: (2018)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

MiR-629-5p Promotes Prostate Cancer Development and Metastasis by Targeting AKAP13
por: Liu, Yangzhou, et al.
Publicado: (2021)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer
por: Ye, Feng, et al.
Publicado: (2019)

Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development
por: Peng, Fu, et al.
Publicado: (2020)

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer
por: Xu, Xin, et al.
Publicado: (2016)

Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
por: Peng, Fu, et al.
Publicado: (2022)

High expression of microRNA-183/182/96 cluster as a prognostic biomarker for breast cancer
por: Song, Cailu, et al.
Publicado: (2016)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4
por: Lu, Jinlai, et al.
Publicado: (2018)

Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma
por: Li, Xuesen, et al.
Publicado: (2020)

CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells
por: Chikuda, Junichiro, et al.
Publicado: (2020)

Exosome-Encapsulated miR-31, miR-192, and miR-375 Serve as Clinical Biomarkers of Gastric Cancer
por: He, Jing, et al.
Publicado: (2023)

Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
por: Fkih M’hamed, Insaf, et al.
Publicado: (2015)

Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
por: Liu, Aiqun, et al.
Publicado: (2023)

Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?
por: Wang, Jin, et al.
Publicado: (2019)

LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
por: Kong, Yan, et al.
Publicado: (2019)

Serum miR-214 Serves as a Biomarker for Prodromal Parkinson’s Disease
por: Li, Lanting, et al.
Publicado: (2021)

miR-320a serves as a negative regulator in the progression of gastric cancer by targeting RAB14
por: Li, Yongyuan, et al.
Publicado: (2017)

The Level of Conus Medullaris in 629 Healthy Japanese Individuals
por: Nakashima, Hiroaki, et al.
Publicado: (2021)

The Potential of miR-370-3p and miR-495-3p Serving as Biomarkers for Sepsis-Associated Acute Kidney Injury
por: Ma, Wenlu, et al.
Publicado: (2022)

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia
por: Zhang, Lidan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_978uei9fv62thrv8p5597a09sr